1. Inicio
  2. Proyectos y Estudios
  3. A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of 3 Active Dose Regimens of MORF-057 in Adults with Moderately to Severely Active Crohn’s Disease (GARNET).

A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of 3 Active Dose Regimens of MORF-057 in Adults with Moderately to Severely Active Crohn’s Disease (GARNET).

Datos básicos

ENSAYO CLÍNICO MORF-057-203 HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE Año de incio: 2024

Documentos

  • No hay documentos

Participantes

Ver todos los Investigadores

Grupos

Financiadores - Promotores

MORPHIC THERAPEUTIC INC.

Compartir